Luxembourg Pharmaceutical and Medical Goods Expenditure Share (2025)
Luxembourg's Pharmaceutical and Medical Goods Expenditure Share: 13.2 % of current health expenditure in 2025, +0.2pp YoY.
Luxembourg (2025)
13.2
% of current health expenditure
+0.2pp YoY
YoY Change
+0.2pp
percentage points
Trend
up
Series length
10
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2025 | 13.2 | +0.2pp |
| 2024 | 13 | unchanged |
| 2023 | 13 | -0.4pp |
| 2022 | 13.4 | +0.1pp |
| 2021 | 13.3 | +0.1pp |
| 2020 | 13.2 | unchanged |
| 2019 | 13.2 | -0.6pp |
| 2018 | 13.8 | -0.3pp |
| 2017 | 14.1 | -0.1pp |
| 2016 | 14.2 | n/a |
About this Dataset
Luxembourg recorded 13.2 % of current health expenditure in 2025. The latest change was +0.2pp. Across 2016–2025 the series ranges from 13 in 2024 to 14.2 in 2016.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Luxembourg.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Luxembourg. It is published by Eurostat and updated annually.
The most recent observation covers 2025. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2016–2025 (10 observations).
The series peaked at 14.2 % of current health expenditure in 2016 and reached its lowest recorded value of 13 in 2024. The latest reading of 13.2 in 2025 represents a change of +0.2pp.